Clinical Trial Update: Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates for VX-121 in healthy subjects and cystic fibrosis patients have completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-121

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-07-14